Expression of concern
The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma
Paper Information
Record ID:
20830
Author(s):
Journal:
Publication Date:
July 06, 2010
Retraction Date:
July 01, 2019
(6.4 years years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1158/1078-0432.CCR-19-1601Additional Notes:
David Panka has ORI finding of misconduct - see https://ori.hhs.gov/content/case-summary-panka-david;
Citations (177)
177
Total Citations23
Post-Retraction(13.0%)
134
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
14
After 2+ years
2095
Days since retraction (latest)
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Mar 2025
2095 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jan 2025
2041 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Sep 2024
1913 days after retraction
Unveiling the Role of PIK3R1 in Cancer: A Comprehensive Review of Regulatory Signaling and Therapeutic Implications
Ishita Gupta, Daria A. Gaykalova
Seminars in Cancer Biology
Published: Aug 2024
9 citations
9 citations
1883 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Apr 2024
1754 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Mar 2024
1726 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Mar 2024
1705 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Dec 2023
1623 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jan 2023
1299 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Aug 2022
1130 days after retraction
Mammalian Target of Rapamycin as the Therapeutic Target of Vascular Proliferative Diseases: Past, Present, and Future
Wenqian Huang, Yan Zou, Ying Tian et al. (8 authors)
Journal of Cardiovascular Pharmacology
Published: Jan 2022
5 citations
5 citations
919 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jan 2022
915 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Nov 2021
876 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jul 2021
757 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2021
686 days after retraction
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
A. Hage, Olivier Dormond
Cancers
Open Access
Published: Mar 2021
36 citations
36 citations
625 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Mar 2021
623 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Oct 2020
458 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Aug 2020
397 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2020
322 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2020
305 days after retraction
Targeting Strategies for Renal Cancer Stem Cell Therapy
Pengchao Fang, Liuting Zhou, Lee Yong Lim et al. (6 authors)
Current Pharmaceutical Design
Published: Mar 2020
12 citations
12 citations
261 days after retraction
Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities
Anna Brodziak, Paweł Sobczuk, Ewa Bartnik et al. (7 authors)
Nature Reviews Urology
Published: Oct 2019
29 citations
29 citations
101 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jul 2019
Same day as retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Jun 2019
17 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: May 2019
53 days before retraction
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang, Ji Nie, Xuelei Ma et al. (6 authors)
Molecular Cancer
Open Access
Published: Feb 2019
1352 citations
1352 citations
132 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Oct 2018
245 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Sep 2018
277 days before retraction
The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies
JoaquĂn Araos HenrĂquez, Jonathan P. Sleeman, Boyan K. Garvalov
Clinical & Experimental Metastasis
Published: Aug 2018
34 citations
34 citations
304 days before retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Feb 2018
510 days before retraction
Quick Stats
Total Citations:
177
Years Since Retraction:
6.4 years
Open Access:
Yes
Last Checked:
Never